HTA303 Are BSC and Patient-Individual Therapy as Appropriate Comparators Detrimental for AMNOG Benefit Assessment and Price Rebates in Germany?
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1986
https://www.valueinhealthjournal.com/article/S1098-3015(23)05116-1/fulltext
Title :
HTA303 Are BSC and Patient-Individual Therapy as Appropriate Comparators Detrimental for AMNOG Benefit Assessment and Price Rebates in Germany?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05116-1&doi=10.1016/j.jval.2023.09.1986
First page :
Section Title :
Open access? :
No
Section Order :
11433